About This Hepatic Steatosis Index Calculator
This Hepatic Steatosis Index (HSI) Calculator is a noninvasive clinical tool used to screen for Nonalcoholic Fatty Liver Disease (NAFLD), now also known as MASLD. By combining readily available parameters—ALT, AST, BMI, sex, and diabetes status—it generates a score that correlates with the probability of having hepatic steatosis. It serves as an effective initial step to identify patients who may benefit from further diagnostic imaging, such as a liver ultrasound.
The Formula Explained
The HSI score is calculated using a linear regression formula developed by Lee et al.
$$ \text{HSI} = 8 \times (\frac{\text{ALT}}{\text{AST}}) + \text{BMI} \; (+2 \text{ if Female}) \; (+2 \text{ if Diabetes}) $$
Clinical Interpretation & Limitations
The HSI score provides a probability of hepatic steatosis based on validated cutoffs.
- HSI < 30: Indicates a low probability of hepatic steatosis. In the original derivation cohort, this cutoff ruled out NAFLD with a sensitivity of 93.1%.
- HSI > 36: Indicates a high probability of hepatic steatosis. In the original derivation cohort, this cutoff detected NAFLD with a specificity of 92.4%.
- Indeterminate Range (30-36): The score is not definitive in this range, and further evaluation, such as ultrasonography, may be warranted based on clinical suspicion.
Limitations
The HSI was developed and validated in a Korean cohort, and its performance may vary in other populations. It is a screening tool and not a substitute for diagnostic imaging for confirmation of steatosis. The score’s accuracy can be affected by other causes of elevated liver enzymes.
Frequently Asked Questions (FAQ)
1. What is the difference between HSI and FIB-4/APRI?
HSI is used to predict the presence of fat in the liver (steatosis), while FIB-4 and APRI are used to predict the degree of scarring (fibrosis). A patient can have steatosis without significant fibrosis. HSI is often a first step, and if positive, a fibrosis score may then be calculated.
2. What is NAFLD/MASLD?
NAFLD (Nonalcoholic Fatty Liver Disease) is the buildup of excess fat in the liver of people who drink little to no alcohol. It was recently renamed MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) to better reflect its connection to metabolic syndrome.
3. My HSI score is high (>36). What should I do?
A high HSI score suggests a high likelihood of fatty liver. You should consult your healthcare provider. They will likely recommend further tests, such as a liver ultrasound, and discuss lifestyle modifications like diet and exercise.
4. Can I lower my HSI score?
Yes. Since HSI is heavily influenced by BMI and liver enzymes related to metabolic health, the score can often be improved through lifestyle changes. Weight loss, a balanced diet, and regular exercise are the cornerstones of managing NAFLD/MASLD and can lead to a reduction in the HSI score.
5. Why is the ALT/AST ratio used in the formula?
In NAFLD/MASLD, liver inflammation often causes ALT to rise more significantly than AST, typically leading to an ALT/AST ratio > 1. This ratio is a key component that helps the HSI model differentiate NAFLD from some other liver conditions where AST is often higher than ALT (e.g., alcoholic liver disease).
📖 Sources:
- Lee JH, Kim D, Kim HJ, et al. (2010). Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Digestive and Liver Disease, 42(7), 503-508. PMID: 19766548.
- Rinella ME, Lazarus JV, Ratziu V, et al. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78(6), 1966-1986. PMID: 37363821.
- Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. (2023). AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology, 77(5), 1797-1835. PMID: 36727674.
- European Association for the Study of the Liver (EASL), EASD, EASO. (2016). EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology, 64(6), 1388-1402. PMID: 27062661.
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.
